VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CRDL
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CRDLCardiol Therapeutics Inc.
$1.01$113M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCRDLQuarterly Financials

Cardiol Therapeutics Inc. (CRDL) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Cardiol Therapeutics Inc. (CRDL) quarterly income statement — complete revenue, gross profit & net income history

CRDL Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue000000000000000000078.76K
Revenue Growth %----------------100%----
Cost of Goods Sold26.78K25.95K00033.7K045.24K61.62K50.37K47.77K44.13K43.04K42.81K39.36K41.76K42.85K43.95K43.81K0
COGS % of Revenue--------------------
Gross Profit-26.78K-25.95K000-33.7K0-45.24K-61.62K-50.37K-47.77K-44.13K-43.04K-42.81K-39.36K-41.76K-42.85K-43.95K-43.81K78.76K
Gross Margin %-------------------100%
Gross Profit Growth %-22.98%-100%100%33.1%100%-2.51%-43.19%-17.66%-21.35%-5.68%-0.43%2.59%10.16%-153.02%1.39%4.11%-2.06%286.73%
Operating Expenses9.71M8.03M10.18M7.68M8.43M6.91M14.14M5.61M8.34M6.01M5.59M4.72M5.71M6.67M9.51M7.13M7.78M10.31M7.97M6.5M
OpEx % of Revenue-------------------8255.55%
Selling, General & Admin4.74M5.26M5.37M4.92M4.65M3.97M10.39M3.63M5.02M2.96M3.69M2.09M2.66M2.52M5.84M3.7M4.71M7.52M5.92M4.43M
SG&A % of Revenue-------------------5625.18%
Research & Development4.96M2.74M4.79M2.73M3.76M2.94M3.75M1.98M3.32M3.05M1.9M2.62M3.05M4.14M3.68M3.42M3.07M2.79M2.04M2.07M
R&D % of Revenue-------------------2630.37%
Other Operating Expenses025.98K25.55K25.47K24.99K00028.22K00000000000
Operating Income-9.73M-8.03M-10.18M-7.68M-8.43M-6.94M-14.14M-5.66M-8.41M-6.06M-5.64M-4.76M-5.76M-6.71M-9.55M-7.17M-7.82M-10.36M-8.01M-6.42M
Operating Margin %--------------------8155.55%
Operating Income Growth %-15.46%-15.69%28.01%-35.7%-0.28%-14.59%-150.92%-18.74%-46%9.71%41.01%33.55%26.41%35.21%-19.25%-11.6%-9.49%-37.15%-142.6%-144.1%
EBITDA-9.71M-8M-10.15M-7.65M-8.4M-6.91M-13.94M-5.61M-8.34M-6.01M-5.59M-4.72M-5.71M-6.67M-9.51M-7.13M-7.78M-10.31M-7.97M-6.37M
EBITDA Margin %--------------------8086.2%
EBITDA Growth %-15.48%-15.88%27.15%-36.34%-0.72%-14.99%-149.46%-18.89%-46.02%9.89%41.27%33.78%26.56%35.35%-19.41%-11.9%-9.55%-37.4%-144.45%-145.97%
D&A (Non-Cash Add-back)26.78K25.98K25.55K25.47K24.99K33.7K201.09K45.24K61.62K50.37K47.77K44.13K43.04K42.81K39.36K41.76K42.85K43.95K43.81K54.62K
EBIT-9.73M-8.03M-9.96M-7.68M-8.43M-5.68M-14.14M-4.82M-8.41M-5.76M-4.37M-5.64M-5.24M-5.54M-5.76M-5.04M-7.16M-4.95M-7.81M-6.42M
Net Interest Income201.24K175.21K122.26K180.67K248.27K306.77K201.86K307.41K377.29K338.24K515.54K528.7K545.93K584.65K389.34K191.34K72.31K27.77K35.93K25.48K
Interest Income201.24K175.21K122.26K180.67K248.27K306.77K201.86K307.41K377.29K338.24K515.54K528.7K545.93K584.65K389.34K191.34K72.31K27.77K35.93K25.48K
Interest Expense000000000-0000000000
Other Income/Expense-1.11M818.41K215.82K-678.21K141.41K1.26M1.41M840.65K-774.15K295.62K1.27M-872.92K515.21K1.17M3.79M2.13M666.84K5.41M199.9K-137.63K
Pretax Income-10.85M-7.21M-9.96M-8.35M-8.29M-5.68M-12.73M-4.82M-9.18M-5.76M-4.37M-5.64M-5.24M-5.54M-5.76M-5.04M-7.16M-4.95M-7.81M-6.56M
Pretax Margin %--------------------8330.3%
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-10.85M-7.21M-9.96M-8.35M-8.29M-5.68M-12.73M-4.82M-9.18M-5.76M-4.37M-5.64M-5.24M-5.54M-5.76M-5.04M-7.16M-4.95M-7.81M-6.56M
Net Margin %--------------------8330.3%
Net Income Growth %-30.88%-26.91%21.72%-73.47%9.72%1.37%-191.59%14.56%-75.12%-3.94%24.22%-11.86%26.75%-12.06%26.25%23.2%-0.95%34.8%-137.06%-146.54%
Net Income (Continuing)-10.85M-7.21M-9.96M-8.35M-8.29M-5.68M-12.73M-4.82M-9.18M-5.76M-4.37M-5.64M-5.24M-5.54M-5.76M-5.04M-7.16M-4.95M-7.81M-6.56M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.10-0.07-0.12-0.10-0.10-0.12-0.18-0.10-0.14-0.12-0.09-0.12-0.11-0.12-0.13-0.10-0.14-0.11-0.23-0.16
EPS Growth %0.4%40.08%33.33%-4.28%28.57%0%-95.65%20.08%-27.27%0%29.23%-20%21.43%-9.09%43.48%37.5%46.15%62.07%-76.92%-23.08%
EPS (Basic)-0.10-0.07-0.12-0.10-0.10-0.12-0.18-0.10-0.14-0.12-0.09-0.12-0.11-0.12-0.13-0.10-0.14-0.11-0.23-0.16
Diluted Shares Outstanding108.99M100.26M84.73M82.65M82.61M69.84M69.84M68.75M67.26M65.35M64.49M64.11M64.09M64.04M62.34M61.93M61.93M56.89M43.17M40.06M
Basic Shares Outstanding108.99M100.26M84.73M82.65M82.61M69.84M69.84M68.75M67.26M65.35M64.49M64.11M64.09M63.83M62.34M61.93M61.92M56.89M43.17M40.06M
Dividend Payout Ratio--------------------